21 January 2025: Viona launches Fludrocortisone Acetate Tablets, USP 0.1 mg
15 January 2025: Viona launches Doxepin Tablets, 3 mg and 6 mg
We’re setting a new standard for high-quality, low-cost generics.
Viona Pharmaceuticals is a fast-growing generic pharmaceutical company with its headquarters in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Zydus Lifesciences Limited, a fully integrated, global healthcare provider.
Learn More About UsFludrocortisone Acetate Tablets, USP
COMPARED TO: Florinef®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Corticosteroid
Valsartan Tablets, USP
COMPARED TO: Diovan®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Antihypertension
PRODUCTS
Viona is currently marketing a range of Oral Solids and Topical products. We have a vast number of generic pharmaceutical products in the pipeline, which we are excited to introduce to the market soon.
Explore our Products
21 January 2025: Viona launches Fludrocortisone Acetate Tablets, USP 0.1 mg
15 January 2025: Viona launches Doxepin Tablets, 3 mg and 6 mg